1. Home
  2. Clinical Topics
  3. FDA warns of counterfeit Avastin
Clinical TopicsDrugs and DevicesWeb Exclusives

FDA warns of counterfeit Avastin

Share

On Feb. 14, the U.S. Food and Drug Administration notified healthcare professionals and patients about a counterfeit version of Avastin 400 mg/16mL, which may have been purchased and used by some medical practices in the United State. The counterfeit version of Avastin does not contain the medicine’s active ingredient, bevacizumab. Read more.

Leave a Reply

Your email address will not be published. Required fields are marked *

Fill out this field
Fill out this field
Please enter a valid email address.

cheryl meeGet your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.

NurseLine Newsletter

  • Hidden

*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.

Recent Posts